SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
neutralization tests
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
20
1
Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats
2
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
3
Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers
4
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin
5
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
6
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease
7
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly
8
The immunologic response to infection with respiratory syncytial virus in infants
9
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein
10
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
11
Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus
12
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group
13
Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old
14
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia
15
Studies on enterotoxin from Escherichia coli associated with acute diarrhea in man
16
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum
17
Influence of immunological factors in respiratory syncytial virus disease
18
Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex
19
Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret
20
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness